146 related articles for article (PubMed ID: 9040136)
21. Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.
Nakahara H; Noguchi S; Murakami N; Tamura S; Jinnouchi S; Kodama T; Adjei ON; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
Radiology; 1997 Mar; 202(3):765-72. PubMed ID: 9051032
[TBL] [Abstract][Full Text] [Related]
22. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions.
Mahfouz AE; Hamm B; Wolf KJ
Radiology; 1994 Jan; 190(1):49-52. PubMed ID: 8259426
[TBL] [Abstract][Full Text] [Related]
23. Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings.
Geirnaerdt MJ; Bloem JL; Eulderink F; Hogendoorn PC; Taminiau AH
Radiology; 1993 Mar; 186(3):813-7. PubMed ID: 8430192
[TBL] [Abstract][Full Text] [Related]
24. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
Kim B; Semelka RC; Ascher SM; Chalpin DB; Carroll PR; Hricak H
Radiology; 1994 Oct; 193(1):239-45. PubMed ID: 8090898
[TBL] [Abstract][Full Text] [Related]
25. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT.
Yamashita Y; Honda S; Nishiharu T; Urata J; Takahashi M
AJR Am J Roentgenol; 1996 May; 166(5):1151-5. PubMed ID: 8615260
[TBL] [Abstract][Full Text] [Related]
26. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging.
Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Schaeffer U; Brix G; Essig M; Hoffmann U; Zuna I; Schönberg S; van Kaick G
Radiology; 1996 Nov; 201(2):531-9. PubMed ID: 8888254
[TBL] [Abstract][Full Text] [Related]
27. MR imaging of spondylitis with gadopentetate dimeglumine enhancement.
Demaerel P; van Ongeval C; Wilms G; Lateur L; Baert AL
J Neuroradiol; 1994 Dec; 21(4):245-54. PubMed ID: 7884486
[TBL] [Abstract][Full Text] [Related]
28. Gadolinium-enhanced MR aortography.
Prince MR
Radiology; 1994 Apr; 191(1):155-64. PubMed ID: 8134563
[TBL] [Abstract][Full Text] [Related]
29. The use of gadolinium in the MR evaluation of soft tissue tumors.
Kransdorf MJ; Murphey MD
Semin Ultrasound CT MR; 1997 Aug; 18(4):251-68. PubMed ID: 9285993
[TBL] [Abstract][Full Text] [Related]
30. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
[TBL] [Abstract][Full Text] [Related]
31. Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
Beltran J; Chandnani V; McGhee RA; Kursunoglu-Brahme S
AJR Am J Roentgenol; 1991 Mar; 156(3):457-66. PubMed ID: 1899738
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
Helbich TH; Becherer A; Trattnig S; Leitha T; Kelkar P; Seifert M; Gnant M; Staudenherz A; Rudas M; Wolf G; Mostbeck GH
Radiology; 1997 Feb; 202(2):421-9. PubMed ID: 9015068
[TBL] [Abstract][Full Text] [Related]
33. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
[TBL] [Abstract][Full Text] [Related]
34. Gadopentetate-enhanced magnetic resonance imaging with fat saturation in the evaluation of Morton's neuroma.
Unger HR; Mattoso PQ; Drusen MJ; Neumann CH
J Foot Surg; 1992; 31(3):244-6. PubMed ID: 1619223
[TBL] [Abstract][Full Text] [Related]
35. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging--parametric "first-pass" images depict tissue vascularization and perfusion.
Verstraete KL; De Deene Y; Roels H; Dierick A; Uyttendaele D; Kunnen M
Radiology; 1994 Sep; 192(3):835-43. PubMed ID: 8058957
[TBL] [Abstract][Full Text] [Related]
36. Spectral presaturation inversion recovery MR imaging sequence after gadolinium injection to differentiate fibrotic scar tissue and neoplastic strands in the mesorectal fat in patients undergoing restaging of rectal carcinoma after neoadjuvant chemo- and radiation therapy.
Quaia E; Ulcigrai V; Coss M; De Paoli L; Ukmar M; Zanconati F; De Pellegrin A; De Manzini N; Cova MA
Acad Radiol; 2011 Nov; 18(11):1365-75. PubMed ID: 21971257
[TBL] [Abstract][Full Text] [Related]
37. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Peterson MS; Baron RL; Murakami T
Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
[TBL] [Abstract][Full Text] [Related]
38. Morton neuroma: evaluation with MR imaging performed with contrast enhancement and fat suppression.
Terk MR; Kwong PK; Suthar M; Horvath BC; Colletti PM
Radiology; 1993 Oct; 189(1):239-41. PubMed ID: 8372200
[TBL] [Abstract][Full Text] [Related]
39. Advances in MR imaging of pediatric musculoskeletal neoplasms.
Lang P; Johnston JO; Arenal-Romero F; Gooding CA
Magn Reson Imaging Clin N Am; 1998 Aug; 6(3):579-604. PubMed ID: 9654586
[TBL] [Abstract][Full Text] [Related]
40. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.
Whitney WS; Herfkens RJ; Jeffrey RB; McDonnell CH; Li KC; Van Dalsem WJ; Low RN; Francis IR; Dabatin JF; Glazer GM
Radiology; 1993 Dec; 189(3):863-70. PubMed ID: 8234717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
